HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

Positron Emission Tomography: Clinical Status in the United States in 1987

Correspondence: For reprints contact: R. Edward Coleman, MD, Box 3808, Dept. of Radiology, Duke University Medical Center, Durham, NC 27710.

ABSTRACT

PET studies are now being used to provide unique clinical information in several conditions. PET is an accurate, noninvasive method of identifying patients with coronary artery disease. Furthermore, PET studies can accurately differentiate patients who will or will not benefit from revascularization procedures. In patients with partial epilepsy being considered for surgery, PET studies provide spatial localization of the focus that complements other tests in improving the surgical management of these patients. PET studies give important diagnostic and prognostic information in the management of patients with gliomas and can direct recurrence of tumor and distinguish it from radiation necrosis. These uses of PET are well documented, and their utility has been independently confirmed in several institutions. Several other areas of research are being pursued with PET, and these will probably develop into clinically useful procedures in the future.

FOOTNOTES

^* Task Force members are David E. Kuhl and Henry N. Wagner, Co-Chairmen, and Abass Alavi, R. Edward Coleman, K. Lance Gould, Steven M. Larson, Mark A. Mintun, Barry A. Siegel, and Paul K. Strudier.